A detailed history of Littlejohn & CO LLC transactions in Alvotech stock. As of the latest transaction made, Littlejohn & CO LLC holds 1,318,534 shares of ALVO stock, worth $16.8 Million. This represents 6.78% of its overall portfolio holdings.

Number of Shares
1,318,534
Previous 1,218,534 8.21%
Holding current value
$16.8 Million
Previous $14.9 Million 7.68%
% of portfolio
6.78%
Previous 7.72%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$11.4 - $14.51 $1.14 Million - $1.45 Million
100,000 Added 8.21%
1,318,534 $16 Million
Q1 2024

May 09, 2024

BUY
$11.36 - $17.27 $978,584 - $1.49 Million
86,143 Added 7.61%
1,218,534 $14.9 Million
Q1 2023

May 15, 2023

BUY
$10.01 - $14.03 $11.3 Million - $15.9 Million
1,132,391 New
1,132,391 $14.6 Million

Others Institutions Holding ALVO

About Alvotech


  • Ticker ALVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 248,650,000
  • Market Cap $3.17B
  • Description
  • Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...
More about ALVO
Track This Portfolio

Track Littlejohn & CO LLC Portfolio

Follow Littlejohn & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Littlejohn & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Littlejohn & CO LLC with notifications on news.